Name: Living with Narcolepsy: Saturday Support Group
Start: 2024-05-04T13:30:00-04:00
End: 2024-05-04T14:30:00-04:00

Aug 15 2019
Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

Posted at Aug 15 2019
h in News by Monica Gow

Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy.

Click here to read their press release.

Print page

Aug 15 2019 Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy

2 events, 1

2 events, 1

2 events, 2

2 events, 2

2 events, 3

2 events, 3

1 event, 4

1 event, 4

1 event, 5

1 event, 5

2 events, 6

2 events, 6

0 events, 7

0 events, 7

2 events, 8

2 events, 8

2 events, 9

2 events, 9

2 events, 10

2 events, 10

1 event, 11

1 event, 11

1 event, 12

1 event, 12

1 event, 13

1 event, 13

0 events, 14

0 events, 14

2 events, 15

2 events, 15

2 events, 16

2 events, 16

2 events, 17

2 events, 17

1 event, 18

1 event, 18

1 event, 19

1 event, 19

1 event, 20

1 event, 20

0 events, 21

0 events, 21

2 events, 22

2 events, 22

2 events, 23

2 events, 23

3 events, 24

3 events, 24

1 event, 25

1 event, 25

1 event, 26

1 event, 26

2 events, 27

2 events, 27

Wake Up Narcolepsy 2024 National Summit

Wake Up Narcolepsy 2024 National Summit

Aug 15 2019
Harmony Biosciences Announces FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy